Patents/Intellectual Property Rights
  • strict warning: Declaration of views_handler_filter_node_status::operator_form() should be compatible with views_handler_filter::operator_form(&$form, &$form_state) in /home/nwrageadmin/d6.nwrage.org/sites/all/modules/views/modules/node/views_handler_filter_node_status.inc on line 13.
  • strict warning: Declaration of views_plugin_style_default::options() should be compatible with views_object::options() in /home/nwrageadmin/d6.nwrage.org/sites/all/modules/views/plugins/views_plugin_style_default.inc on line 24.

HIGH COURT RULES FOR MONSANTO IN PATENT CASE

Patents/Intellectual Property Rights

SUMMARY: "The Supreme Court said Monday that an Indiana farmer violated Monsanto Co.’s patents on soybean seeds resistant to its weed-killer by growing the beans without buying new seeds from the corporation. The justices unanimously rejected the farmer’s argument that cheap soybeans he bought from a grain elevator are not covered by the Monsanto patents, even though most of them also were genetically modified to resist the company’s Roundup herbicide.

Monsanto Wins Case on Genetically Altered Soybeans

Patents/Intellectual Property Rights

WASHINGTON – The Supreme Court ruled unanimously on Monday that farmers
could not use Monsanto’s patented genetically altered soybeans to create new
seeds without paying the company a fee.

The ruling has implications for many aspects of modern agriculture and for
businesses based on vaccines, cell lines and software. But Justice Elena
Kagan, writing for the court, emphasized that the decision was narrow.

“Our holding today is limited — addressing the situation before us, rather
than every one involving a self-replicating product,” she wrote. “We

BIOTECH INDUSTRY AT STAKE IN HUMAN GENE PATENT DECISION

Patents/Intellectual Property Rights

SUMMARY: "For 30 years, biotechnology innovators have secured thousands of U.S. patents on genes, defining the legal rights to medical and agricultural products worth hundreds of billions of dollars. Now the U.S. Supreme Court is considering whether that was all a big mistake. The court next week will debate whether human genes can be patented, hearing arguments from doctors, patients and scientists who say patents are stifling clinical testing and research. The group is challenging Myriad Genetics Inc.‘s patents on genes linked to breast and ovarian cancer.

JUSTICES APPEAR SKEPTICAL OF PATENTING HUMAN GENES

Patents/Intellectual Property Rights

SUMMARY: "In a case considered pivotal to the future of science and medicine, the justices of the U.S. Supreme Court seemed skeptical Monday about a claim that human genes can be patented. [...] At issue in Monday’s case were two genes, known as BRCA 1 and 2, which indicate a hereditary link to breast and ovarian cancer. Myriad Genetics, located in Utah, found and isolated the genes, and then patented them. But the scientific and patient community rebelled, challenging the patents in court.

SUPREME COURT TO HEAR MONSANTO SEED PATENT CASE

Patents/Intellectual Property Rights

SUMMARY: "Yet the 75-year-old farmer from southwestern Indiana will face off Tuesday against the world’s largest seed company, Monsanto, in a Supreme Court case that could have a huge impact on the future of genetically modified crops, and also affect other fields from medical research to software. At stake in Mr. Bowman’s case is whether patents on seeds — or other things that can self-replicate — extend beyond the first generation of the products.

Syndicate content